西南证券发布赛诺医疗研报，冠脉业务稳健增长，盈利能力持续提升

Group 1 - The coronary business shows steady growth with continuous improvement in profitability [1] - The neurointerventional business demonstrates resilience, with significant new products entering the harvest phase [1] - The internationalization strategy is accelerating, leading to key breakthroughs in overseas markets [1]